165 related articles for article (PubMed ID: 37847172)
1. Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis.
Kuang Y; Feng J; Jiang Y; Jin Q; Wang Q; Zhang C; He Y
Int J Immunopathol Pharmacol; 2023; 37():3946320231206966. PubMed ID: 37847172
[TBL] [Abstract][Full Text] [Related]
2. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
3. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Singh S; Arcaroli JJ; Orlicky DJ; Chen Y; Messersmith WA; Bagby S; Purkey A; Quackenbush KS; Thompson DC; Vasiliou V
Pancreas; 2016 Jan; 45(1):117-22. PubMed ID: 26566217
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
Chen Y; Orlicky DJ; Matsumoto A; Singh S; Thompson DC; Vasiliou V
Biochem Biophys Res Commun; 2011 Feb; 405(2):173-9. PubMed ID: 21216231
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde Dehydrogenase 1B1 Is Implicated in DNA Damage Response in Human Colorectal Adenocarcinoma.
Tsochantaridis I; Kontopoulos A; Voulgaridou GP; Tsifintaris M; Triantafyllou C; Pappa A
Cells; 2022 Jun; 11(13):. PubMed ID: 35805102
[TBL] [Abstract][Full Text] [Related]
8. Spermine synthase (
Pan X; Xue L; Sun Y
Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
[TBL] [Abstract][Full Text] [Related]
9. PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis.
Bao L; Sun K; Zhang X
Channels (Austin); 2021 Dec; 15(1):680-696. PubMed ID: 34796785
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and immunological role of Fam20C in pan-cancer.
Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
[TBL] [Abstract][Full Text] [Related]
11. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
Yang Q; Zeng S; Liu W
PeerJ; 2023; 11():e15019. PubMed ID: 36949759
[TBL] [Abstract][Full Text] [Related]
12. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
13. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
14. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.
Wang H; Li Y; Zhou D; Li X; Jia S; Qi S; Huang J
Histol Histopathol; 2021 Feb; 36(2):183-194. PubMed ID: 33438176
[TBL] [Abstract][Full Text] [Related]
16. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
Front Genet; 2023; 14():1041042. PubMed ID: 36936420
[No Abstract] [Full Text] [Related]
17. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme.
Stagos D; Chen Y; Brocker C; Donald E; Jackson BC; Orlicky DJ; Thompson DC; Vasiliou V
Drug Metab Dispos; 2010 Oct; 38(10):1679-87. PubMed ID: 20616185
[TBL] [Abstract][Full Text] [Related]
19. Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer.
Ge H; Yan Y; Yan M; Guo L; Mao K
Med Sci Monit; 2020 Jun; 26():e923208. PubMed ID: 32562536
[TBL] [Abstract][Full Text] [Related]
20. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
